A New Self-Controlled Case Series Method for Analyzing Spontaneous Reports of Adverse Events After Vaccination

被引:10
|
作者
Escolano, S. [1 ,2 ]
Hill, C. [3 ]
Tubert-Bitter, P. [1 ,2 ]
机构
[1] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Biostat Team, F-94807 Villejuif, France
[2] Univ Paris 11, Unite Mixte Rech Sci 1018, Villejuif, France
[3] Inst Gustave Roussy, Biostat & Epidemiol Serv, Villejuif, France
关键词
adverse events; intussusception; pharmacoepidemiology; pharmacovigilance; rotavirus; self-controlled case series; spontaneous reporting; vaccines; IDIOPATHIC THROMBOCYTOPENIC PURPURA; SIGNAL-DETECTION METHODS; FALSE DISCOVERY RATES; ROTAVIRUS VACCINATION; RETROSPECTIVE EVALUATION; UNITED-KINGDOM; B VACCINE; PHARMACOVIGILANCE; SAFETY; DATABASE;
D O I
10.1093/aje/kwt128
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In this paper, we propose new methods for analyzing cases of vaccine adverse events spontaneously reported to a surveillance database. The methods use the self-controlled case series approach, extended in several ways with parametric and nonparametric assumptions to account for the specific features of the data (large amount of underreporting and variation of reporting with time since vaccination). This work was motivated by the documented risk of intussusception after RotaShield vaccination (Wyeth-Lederle Vaccines, Radnor, Pennsylvania) and used worldwide spontaneous reports of intussusception occurring after Rotarix vaccination (GlaxoSmithKline Biologics, Research Triangle Park, North Carolina) collected between January 2004 and February 2010. The estimated risk during the 3- to 7-day period after vaccination was approximately 5 times higher after dose 1 of Rotarix than after dose 2, which is similar to published findings on the same topic. We undertook a large simulation study to evaluate the performance of the method in different scenarios, including its robustness to different sample sizes and time-dependent reporting functions. The bias was generally small, the type I error rate was correctly controlled, and the power to detect a risk ratio of 4 was satisfactory, provided that the sample size was over 100. The proposed methods are an effective way to explore and quantify vaccine safety signals from spontaneous reports.
引用
收藏
页码:1496 / 1504
页数:9
相关论文
共 50 条
  • [41] Acute Cardiovascular Events After COVID-19 in England in 2020: A Self-Controlled Case Series Study
    Davidson, Jennifer A.
    Banerjee, Amitava
    Strongman, Helen
    Herrett, Emily
    Smeeth, Liam
    Breuer, Judith
    Warren-Gash, Charlotte
    CLINICAL EPIDEMIOLOGY, 2023, 15 : 911 - 921
  • [42] Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design
    Xu, Stanley
    Newcomer, Sophia
    Nelson, Jennifer
    Qian, Lei
    McClure, David
    Pan, Yi
    Zeng, Chan
    Glanz, Jason
    BIOMETRICAL JOURNAL, 2014, 56 (03) : 513 - 525
  • [43] Within-individual dependence in self-controlled case series models for recurrent events
    Farrington, C. Paddy
    Hocine, Mounia N.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2010, 59 : 457 - 475
  • [44] Bias Correction of Risk Estimates in Vaccine Safety Studies With Rare Adverse Events Using a Self-controlled Case Series Design
    Zeng, Chan
    Newcomer, Sophia R.
    Glanz, Jason M.
    Shoup, Jo Ann
    Daley, Matthew F.
    Hambidge, Simon J.
    Xu, Stanley
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (12) : 1750 - 1759
  • [45] Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform
    Walker, Jemma L.
    Schultze, Anna
    Tazare, John
    Tamborska, Arina
    Singh, Bhagteshwar
    Donegan, Katherine
    Stowe, Julia
    Morton, Caroline E.
    Hulme, William J.
    Curtis, Helen J.
    Williamson, Elizabeth J.
    Mehrkar, Amir
    Eggo, Rosalind M.
    Rentsch, Christopher T.
    Mathur, Rohini
    Bacon, Sebastian
    Walker, Alex J.
    Davy, Simon
    Evans, David
    Inglesby, Peter
    Hickman, George
    MacKenna, Brian
    Tomlinson, Laurie
    Green, Amelia C. A.
    Fisher, Louis
    Cockburn, Jonathan
    Parry, John
    Hester, Frank
    Harper, Sam
    Bates, Christopher
    Evans, Stephen J. W.
    Solomon, Tom
    Andrews, Nick J.
    Douglas, Ian J.
    Goldacre, Ben
    Smeeth, Liam
    McDonald, Helen, I
    VACCINE, 2022, 40 (32) : 4479 - 4487
  • [46] Risk of Encephalitis and Meningitis After COVID-19 Vaccination in South Korea: A Self-controlled Case Series Analysis
    Kim, Ju Hwan
    Yoon, Dongwon
    Ko, Hwa Yeon
    Jung, Kyungyeon
    Sunwoo, Jun-Sang
    Shin, Won Chul
    Byun, Jung-Ick
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 505 - 505
  • [47] Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
    Ju Hwan Kim
    Dongwon Yoon
    Hwa Yeon Ko
    Kyungyeon Jung
    Jun-Sang Sunwoo
    Won Chul Shin
    Jung-Ick Byun
    Ju-Young Shin
    BMC Medicine, 22
  • [48] Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
    Kim, Ju Hwan
    Yoon, Dongwon
    Ko, Hwa Yeon
    Jung, Kyungyeon
    Sunwoo, Jun-Sang
    Shin, Won Chul
    Byun, Jung-Ick
    Shin, Ju-Young
    BMC MEDICINE, 2024, 22 (01)
  • [49] Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis
    Yoon, Dongwon
    Kim, Ju Hwan
    Jeong, Han Eol
    Ko, Hwa Yeon
    Kim, Sung-Ryeol
    Shin, Ju-Young
    ALLERGY, 2024, 79 (03) : 754 - 757
  • [50] Prospective surveillance of vaccine safety using the self-controlled case series method
    Hocine, Mounia N.
    Musonda, Patrick
    Farrington, Paddy C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S117 - S118